BioMarin: Positive Phase 3 Data for Voxzogo in Hypochondroplasia; Shares Very Undervalued
BioMarin reported positive phase 3 data for Voxzogo in children with hypochondroplasia, a rare short‑stature condition. The study met its primary endpoint as patients grew 2.33 centimeters per year faster than placebo and showed significant improvements in arm span. Shares rose nearly 8% on May 21.